A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

Clinical trial NCT07543731 · RECRUITING

Trial details

NCT number: NCT07543731
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Cardiovascular Diseases Atherosclerotic Cardiovascular Disease Hypercholesterolemia, Familial

Start date: 2026-04-02
Primary completion: 2026-10-30
Enrollment: 5995

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.